Which condition is primarily treated by weight loss and the use of oral contraceptives?

Polycystic ovary syndrome (PCOS) is a condition primarily treated with weight loss and the use of oral contraceptives because both strategies target the underlying hormonal imbalances and metabolic issues associated with the syndrome.

PCOS is characterized by hyperandrogenism, insulin resistance, and irregular menstrual cycles, leading to symptoms such as hirsutism, acne, and obesity. Weight loss is significant because it can improve insulin sensitivity, reduce androgen levels, and help restore normal menstrual function in women with PCOS. Even modest weight loss of 5-10% of body weight can yield substantial improvements in reproductive and metabolic parameters.

Oral contraceptives are also an essential part of managing PCOS. They help regulate menstrual cycles, reduce menstrual-related symptoms, and decrease androgen levels, which subsequently helps alleviate symptoms like acne and excessive hair growth. Combining these treatment modalities is often effective in managing the symptoms and long-term health risks associated with PCOS.

In contrast, hypothyroidism is primarily managed with hormone replacement therapy, endometriosis typically requires surgical intervention or hormonal therapies targeting endometrial tissue growth, and premenstrual syndrome (PMS) management often focuses on lifestyle modifications and symptomatic relief rather than oral contraceptives as a primary